Lifecore Biomedical (LFCR) Insider Trading & Ownership $6.18 +0.03 (+0.49%) Closing price 03/7/2025 04:00 PM EasternExtended Trading$6.18 0.00 (0.00%) As of 03/7/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Lifecore Biomedical (NASDAQ:LFCR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage32.20%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$601,593.00Number OfInsiders Selling(Last 12 Months)0 Get LFCR Insider Trade Alerts Want to know when executives and insiders are buying or selling Lifecore Biomedical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LFCR Insider Buying and Selling by Quarter Remove Ads Lifecore Biomedical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/8/2025Paul JosephsCEOBuy17,000$5.74$97,580.00 10/3/2024Wynnefield Partners Small CapMajor ShareholderBuy122,930$4.10$504,013.00 (Data available from 1/1/2013 forward) LFCR Insider Trading Activity - Frequently Asked Questions Who is on Lifecore Biomedical's Insider Roster? The list of insiders at Lifecore Biomedical includes Paul Josephs, and Wynnefield Partners Small Cap. Learn more on insiders at LFCR. What percentage of Lifecore Biomedical stock is owned by insiders? 32.20% of Lifecore Biomedical stock is owned by insiders. Learn more on LFCR's insider holdings. Which Lifecore Biomedical insiders have been buying company stock? The following insiders have purchased LFCR shares in the last 24 months: Paul Josephs ($97,580.00), and Wynnefield Partners Small Cap ($504,013.00). How much insider buying is happening at Lifecore Biomedical? Insiders have purchased a total of 139,930 LFCR shares in the last 24 months for a total of $601,593.00 bought. Lifecore Biomedical Key ExecutivesMr. John D. Morberg (Age 60)Executive VP & CFO Compensation: $520.82kDr. Albert D. Bolles Ph.D. (Age 66)President of Curation Foods, Inc. Compensation: $1.34MDr. Kipling Thacker Ph.D. (Age 69)VP & Chief Scientist Mr. Aaron PerlitshDirector of Internal Audit & Chief Compliance OfficerMr. Darren M. HieberSenior Vice President of Corporate Development & PartnershipsMs. Jackie Q. KleckerExecutive VP & GMMr. Matt AugustsonSenior Vice President of Information TechnologyMr. Parker K. Javid (Age 54)Vice President Compensation: $321.91k More Insider Trading Tools from MarketBeat Related Companies Day One Biopharmaceuticals Insider Buying Rocket Pharmaceuticals Insider Buying Avid Bioservices Insider Buying Cogent Biosciences Insider Buying Prothena Insider Buying Maravai LifeSciences Insider Buying Cronos Group Insider Buying ArriVent BioPharma Insider Buying Avadel Pharmaceuticals Insider Buying Bicycle Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 2 Stocks Insiders Are Buying and 1 They're Selling3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q4 This page (NASDAQ:LFCR) was last updated on 3/8/2025 by MarketBeat.com Staff From Our PartnersA new coin is elbowing its way to the top of the crypto worldWith Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | Sponsored[BREAKING NOW] Gold Is Literally Moving—And So Is Its PriceFor decades, I’ve accurately predicted every major gold move—because the signs were always there. Now, I’m ...Golden Portfolio | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifecore Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LFCR Stock Alerts